Ishiguro H, Hoshi N, Noda SE, Tokuda E, et al. A phase II study combining radiotherapy and atezolizumab/nab-paclitaxel for inoperable or recurrent programmed death-ligand 1-positive triple-negative breast cancer: IMRad-Br study protocol and safety run-in. Breast Cancer 2026 Oct 21. doi: 10.1007/s12282-026-01925.
PMID: 42905375